Hilary Ostwald

Hilary Ostwald is a seasoned professional in clinical operations with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Associate Director of Clinical Operations at Candid Therapeutics since November 2024, Hilary has previously held similar roles at Poseida Therapeutics, Inc. from June 2021 to October 2024, and has advanced through various positions at IQVIA from September 2011 to May 2021, including Director and Clinical Lead. Earlier career highlights include roles at Schering-Plough Research Institute, Premier Research Worldwide, and Chiron Vaccines, where foundational experience as a Clinical Research Associate (CRA) was established. Hilary holds a Bachelor of Arts degree in Biology from the University of San Diego, completed in 1995.